A key House committee on Wednesday formally advanced the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, which will essentially legalize cannabis, to the floor.
Meanwhile, Rep. Dave Joyce (OH-R), co-chair of the Congressional Cannabis Caucus, sent a letter to fellow GOP members explaining why he intends to vote against the MORE Act as drafted. Likewise, he offered them guidance on the “cannabis policy landscape,” reported Marijuana Moment.
Sponsored by House Judiciary Committee Chairman Jerrold Nadler (D), the MORE Act would remove marijuana from the list of federally controlled substances, promote equity in the industry and impose a federal tax on marijuana products to fund various initiatives.
Rep. Joyce opposes the provisions of the MORE Act that “would punish those who have made a point to operate legally at their own personal cost, by placing an additional tax on legal operators to pay for the cost of industry access for illegal operators.”
Joyce pointed at legislation he sponsored, the Common Sense Cannabis Reform Act, a bill that would federally deschedule cannabis and direct the Food and Drug Administration and the Alcohol and Tobacco Tax and Trade Bureau (under the Treasury Department) to regulate marijuana. The introduced bill does not mention any reparations to communities disproportionally affected by the War on Drugs.
“He is determined to make the conversation surrounding the MORE Act among Republicans a responsible dialogue about the inevitable end to prohibition and help other conservatives engage on this important issue,” Katherine Sears, communications director for Joyce, told Marijuana Moment.
Image Via El Planteo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.